Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nikolaos Kentepozidis

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
International Journal of Molecular Sciences|October 13, 2021
Targeting the Interplay between HDACs and DNA Damage Repair for Myeloma TherapyMaria Gkotzamanidou, Elisavet Terpou, Nikolaos Kentepozidis, et al.
Clinical Lung Cancer|June 26, 2016
Management of Resistance to Crizotinib in Anaplastic Lymphoma Kinase-Positive Non-Small-cell Lung CancerAlexios Matikas, Nikolaos Kentepozidis, Vassilis Georgoulias, et al.
Cancer Management and Research|June 18, 2015
Cancer therapy and cardiovascular risk: focus on bevacizumabPanagiota Economopoulou, Athanasios Kotsakis, Ioannis Kapiris, et al.
Diagnostic Microbiology and Infectious Disease|December 26, 2006
In vitro postantibiotic effect of colistin on multidrug-resistant Acinetobacter baumanniiDiamantis Plachouras, Evangelos J Giamarellos-Bourboulis, Nikolaos Kentepozidis, et al.
Clinical Case Reports|January 19, 2017
Extensive cutaneous metastases of pancreatic adenocarcinoma: a case report and review of the literatureIoannis Kotsantis, Panagiota Economopoulou, Konstantinos Dritsakos, et al.
Diagnostic Microbiology and Infectious Disease|February 9, 2005
Postantibiotic effect of antimicrobial combinations on multidrug-resistant Pseudomonas aeruginosaEvangelos J Giamarellos-Bourboulis, Nikolaos Kentepozidis, Anastasia Antonopoulou, et al.
Case Reports in Medicine|May 11, 2013
Adrenal incidentalomas in cancer patients are not always "innocent": a case report and review of the literaturePanagiota Economopoulou, Giannis Mountzios, Ioannis Kotsantis, et al.
Scientific Reports|December 16, 2016
Prognostic value of circulating regulatory T cell subsets in untreated non-small cell lung cancer patientsAthanasios Kotsakis, Filippos Koinis, Afroditi Katsarou, et al.
Journal of Geriatric Oncology|December 9, 2014
Do elderly patients with non-small cell lung cancer get the best out of recent advances in first-line treatment? A comparative study in two tertiary cancer centers in GreeceMarios Bakogeorgos, Giannis Mountzios, Evangelos Bournakis, et al.
Cancer Chemotherapy and Pharmacology|April 30, 2010
Second-line chemotherapy with capecitabine (Xeloda) and docetaxel (Taxotere) in previously treated, unresectable adenocarcinoma of pancreas: the final results of a phase II trialOurania Katopodis, Aris Polyzos, Nikolaos Kentepozidis, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
International Journal of Molecular Sciences|October 13, 2021
Targeting the Interplay between HDACs and DNA Damage Repair for Myeloma TherapyMaria Gkotzamanidou, Elisavet Terpou, Nikolaos Kentepozidis, et al.
Clinical Lung Cancer|June 26, 2016
Management of Resistance to Crizotinib in Anaplastic Lymphoma Kinase-Positive Non-Small-cell Lung CancerAlexios Matikas, Nikolaos Kentepozidis, Vassilis Georgoulias, et al.
Cancer Management and Research|June 18, 2015
Cancer therapy and cardiovascular risk: focus on bevacizumabPanagiota Economopoulou, Athanasios Kotsakis, Ioannis Kapiris, et al.
Diagnostic Microbiology and Infectious Disease|December 26, 2006
In vitro postantibiotic effect of colistin on multidrug-resistant Acinetobacter baumanniiDiamantis Plachouras, Evangelos J Giamarellos-Bourboulis, Nikolaos Kentepozidis, et al.
Clinical Case Reports|January 19, 2017
Extensive cutaneous metastases of pancreatic adenocarcinoma: a case report and review of the literatureIoannis Kotsantis, Panagiota Economopoulou, Konstantinos Dritsakos, et al.
Diagnostic Microbiology and Infectious Disease|February 9, 2005
Postantibiotic effect of antimicrobial combinations on multidrug-resistant Pseudomonas aeruginosaEvangelos J Giamarellos-Bourboulis, Nikolaos Kentepozidis, Anastasia Antonopoulou, et al.
Case Reports in Medicine|May 11, 2013
Adrenal incidentalomas in cancer patients are not always "innocent": a case report and review of the literaturePanagiota Economopoulou, Giannis Mountzios, Ioannis Kotsantis, et al.
Scientific Reports|December 16, 2016
Prognostic value of circulating regulatory T cell subsets in untreated non-small cell lung cancer patientsAthanasios Kotsakis, Filippos Koinis, Afroditi Katsarou, et al.
Journal of Geriatric Oncology|December 9, 2014
Do elderly patients with non-small cell lung cancer get the best out of recent advances in first-line treatment? A comparative study in two tertiary cancer centers in GreeceMarios Bakogeorgos, Giannis Mountzios, Evangelos Bournakis, et al.
Cancer Chemotherapy and Pharmacology|April 30, 2010
Second-line chemotherapy with capecitabine (Xeloda) and docetaxel (Taxotere) in previously treated, unresectable adenocarcinoma of pancreas: the final results of a phase II trialOurania Katopodis, Aris Polyzos, Nikolaos Kentepozidis, et al.
Pageof 5